Cargando…
Contemporary Cardiovascular Risk Assessment for Type 2 Diabetes Including Heart Failure as an Outcome: The Fremantle Diabetes Study Phase II
Background: Type 2 diabetes (T2D) cardiovascular disease (CVD) risk assessment has limitations. The aim of this study was to develop a risk equation adding heart failure (HF) to conventional major adverse cardiovascular events (MACE, myocardial infarction, stroke, and CVD death) and allowing for non...
Autores principales: | Davis, Wendy A., Hellbusch, Valentina, Hunter, Michael L., Bruce, David G., Davis, Timothy M. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290870/ https://www.ncbi.nlm.nih.gov/pubmed/32403446 http://dx.doi.org/10.3390/jcm9051428 |
Ejemplares similares
-
Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II
por: Drinkwater, Jocelyn J., et al.
Publicado: (2020) -
The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II
por: Chubb, S. A. Paul, et al.
Publicado: (2022) -
Incidence and associates of diabetic ketoacidosis in a community-based cohort: the Fremantle Diabetes Study Phase II
por: Davis, Timothy M E, et al.
Publicado: (2020) -
The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II
por: Davis, Wendy A., et al.
Publicado: (2018) -
Serum bicarbonate concentration and the risk of death in type 2 diabetes: the Fremantle Diabetes Study Phase II
por: Chubb, S. A. Paul, et al.
Publicado: (2023)